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The woody, ambergris-Iike odor of trans-decalone derivatives
of type 5 increases with the introduction of equatorial alkyl sub-
stituents in the C(9)-positionand decreases drastically in the corre-.
sponding 9-epi derivatives. Complete stereocontrol of odor per-
ception has been observed for the diastereoisomers of y-bicyclo-
homofarnesal 1 and 2. A similar tendency in odor perception has
been recognized in substituted alcohols of type 12. The sandal-
wood-like ambergris note found in Polywood'": (14) disappeared
in corresponding alkyl substituted acetates. The molecular basis
of the 'steroid-type' scent of some esters of type 39 was hitherto
unknown.
INTRODUCTION
(-)-Y-Bicyc1ohomofarnesal (1) and the corresponding methyl ketone (3)\
oxidative degradation products of (-)-sc1areo12, are ambergris odorants of the
finest quality-, Surprisingly, in the poor odor profile of the diastereoisomers
2 and 4, this particular tonality is lacking, although the 'triaxial rule' of odor
sensation- seems to be fulfilled in all cases. While searching for an explanation
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were carried out on derivatives in the drimane and labdane series, whose
structure modifications only concern C(8) and C(9). Our main interest eon-
cerned the introduction of diastereoisomeric alkyl substituents with varying
chain lengths on C(9) of well known ambergris-type molecules. The bicyclic
ketone 51 served as model, together with ester 14 (Polywoodw), and its odor-
less diastereoisomer 153.
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The odor of ketone 5 intensifies in the methyl- and ethyl-substituted
derivatives of the equatorial series 6 and 8. The same tonality predominates
in the propyl derivative 10 but with diminution of odor intensity. In the axial
series 7, 9, 11 odor strength diminishes already in the first member 7. Ketone
9 possesses little odor and 11 is practically odorless. The odors of the secon-
dary alcohols were highly dependent on polarity and stereochemistry. The
strongest amber note is found in the 9-ethyl derivative 22; it is much less in
higher and lower homologs 16 and 28 and disappears completely in the un-
substituted alcohol 124. The 8-epihomologs 13, 17, 23 and 29 are odorless as
are the 9-epi derivatives 18, 19, 24 and 30. Among the tertiary alcohols 9-nor-
drimanoi 34 possesses an outstanding amber-like odor", diminishing in the
homologs 41 and 49. The 9-epi derivative 43 has a faint animalodor or like
cold cigar ash without any amber note, whereas its diastereoisomers 38, 44
and 51 are odorless. The corresponding esters had a different odor from
the alcohols. Whereas Polywood ® (14) is known to have a distinct odor cha-
racter, the introduction of an equatorial methyl group leads to an important
diminution of the sandalwood-like amber note in ester 20, an odor which dis-
appears completely in the higher homologs 25 and 31. All 8a-acetates 15, 26
and 32 were odorless. Similar observations were made in the 9-epi series. The
Polywood character appears diminished in acetate 21, whereas the other esters
27 and 33 are almost odorless. An extremely faint odor is found in the known
esters 35 and 361 and also in the homologs 45 and 52. Surprisingly, acetate 46
possesses a strong urine- and perspiration-like note, mostly found in certain
steroids" and their related seco-compounds". This steroid-type scent is also
found in the lower and higher homologs 39 and 53, although here it is dimi-
nished and has a woody undertone. An explanation of the molecular basis
for this phenomenon is not yet possible. Of the 9-epi compounds, only 47
exhibited a faint amber note, while the acetates 40, 48 and 54 were odorless.
SYNTHESES
The common precursors for all compounds described in this work are the
diastereoisomeric lactones (+ )-scIareolide (1)8 and 9-epi-scIareolide (XV)9,




Transformations of both lactones 1 and XV into the target molecules have
been achieved by literature procedures and are described in abbreviation in
the experimental part.
1
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EXPERIMENTAL
(with the valuable collaboration ofELiane Cristoforetti and Beatrice Frei)
Melting points (m. p.) are not corrected. Specific rotations ([alD) were measured
in CHCl3 at 20° as - 10/0solution with a Perkin Elmer 141 polarimeter. Preparative
column chromatography was performed on silicagel (Merck 60, less than 230 mesh).
Gas chromatography (GC) was carried out on a) Carlo Erba Fractovap 4200 us ing
glass columns (ID = 3 mm) 3 m Carbowax (15'0/0)or 3 m SE 30 (150/0)on Chromosorb
W, 60-90 mesh ; b) Carlo Erba Fractovap 2900 us ing capillary columns (Chrompack):
1. 10 m and Bruker HX 90; measurements were run in CDCl3 with tetramethylsilane
as spectra was carried out on the following apparatus. IR: Perkin-Elmer 297; cha-
racteristic band positions are given in cm-lo lH_ and 13C-NMR:Bruker WH 360
and Bruker HX 90; measurements were run in CDCl3 with tetramethylsilane as
internal standard (o = 0.00 ppm) ; abbreviations: s, singlet, d = doublet, t = triplet,
m = multiplet, br = broad, J = spin-spin coupling constant in Hz, Wt/2 = half-width
in Hz. MS: Varian MAT 112, using electrons of ca. 70 eV energy. - The starting
material for all products was sclareolide (1)* (m. p. 123-125°; [alD20 = +43°) from
Reynolds, USA. Numbering and configurations follow Chem. Abstr. nomenclature.
Preparation of Compounds 6 and 7.
Scheme 4
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Reagents: a) Al(i-BuhH, toluene/-78° 13; b) (AchO, pyridine, then pyrolyzed in
N2-stream at 350°; c) 03/EtOH/-700, then NaBH4 -+ RT.; d) (AchO, pyridine/reflux/20
h; e) 03/AcOEt/-700, then reduced with Zn-powder/acetic acid; f) N2-stream/4700;
g) Pt02/AcOEt, H2; h) NaOMe, MeOH/reflux/1 h; after 1 h equilibrrum was reached.
already reached.
• Roman numerals are used throughout this work for starting materials and
intermediates not submitted to sensory evaluation.
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12-Nordriman-8-one (6). The product was crystallized from pentane: m. p.
58-60°, [a]o20 = -83°. IR: 1720. lH-NMR: 0.73 (s, 3H, 0.88 (s, 3H), 0.90 (d, J = 6,
3H), 0.99 (s, 3H). MS: 208 (58, M+·), 193 (13), 175 (22), 166 (26), 137 (76), 123 (69),
109 (43), 95 (78), 81 (85), 67 (66), 55 (80), 41 (100).
(9j3H)-12-Nordriman-8-one (7). The product was purified by chromatography
on Si02 (Merck 60) at 4 bars with cyclohexanejether 98 : 2. [a]o20 = -28.5°. lH-NMR:
0.874 (s, 3H), 0.936 (s, 3H), 0.975 (s, 3H), 1.105 (d, J = 7, 3H). MS: 208 (33, M+.),
193 (8), 175 (24), 166 (28), 137 (53), 123 (53), 109 (39), 95 (60), 81 (67), 55 (71), 41 (100).













Reagents: a) LiAIH(, THFjrefluxj2 h; b) MeLi, ether; after 48 h reflux only 600/0
transformation; c) (AC)20, CH3COCl/pyridinej400j4 h14; d) (Acl20, pyridinej1000j1 h.
16 and 17 were purified by chromatography on Si02 with cyclohexane/ether
95: 5.
12-Nordriman-8j3-ot (16). M. p. 65-66°, [a]D20 = 0°. IR (CDC1a): 3650, 3480. lH-NMR:
0.86 (s, 3H), 0.88 (s, 3H), 0.99 (s, 3H), 0.945 (d, J = 7, 3H), 3.76 (m, Wl/, = 6, IH).
MS: 210 (6, M·+), 192 (13), 177 (51), 137 (36), 124 (83), 109 (87), 95 (62), 81 (72), 69 (67),
55 (75), 41 (100).
12-Nordriman-8a-ot (17). M. p. 78-80°, [a]o20 = -35.4°. lH-NMR: 0.783 (s, 3H),
0.816 (s, 3H), 0.875 (s, 3H), 0.91 (d, J = 6, 3H), 3.37 (ddd, Ji = 5, J2 = ]s = 10, IH).
MS: 210 (2, M+·), 192 (23), 177 (66), 163 (28), 137 (82), 124 (54), 109 (78), 95 (64),
81 (72), 69 (68), 55 (78), 41 (100).
12-Nordriman-8j3-yL Acetate (20). [a]o20 = +32.4°. IR: 1740. lH-NMR: 2.1 (s, 3H),
4.9 (m, lH). MS: 252 (O, M·+), 192 (22), 177 (46), 149 (27), 136 (36), 124 (72), 109 (43),
95 (42), 81 (51), 69 (42), 55 (42), 43 (100).
J
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Driman-8fJ-ot (37). [a]n20 = -12.3°. IR (CDCh): 3630, 3470. lH-NMR: 0.845 (s,
3H), 0.873 (s, 3H), 0.895 (d, J = 7, 3H), 0.947 (s, 3H), 1.12 (s, 3H). MS: 224 (7, M··),
209 (13), 191 (53), 177 (21), 153 (17), 137 (23), 123 (24), 109 (63), 97 (53), 83 (60),
71 (91), 55 (67), 43 (100).
Driman-8fJ-ut Acetate (39). [a]n20 = +36.6°. m: 1740. lH-NMR: 0.88 (s, 3H),
0.90 (d, J=5, 3H), 0.95 (s, 3H), 1.47 (s, 3H), 2.0 (s, 3H). MS: 266 (O, M·1, 206 (34),
191 (41), 136 (24), 124 (56), 109 (93), 95 (40), 82 (96), 69 (40), 55 (37), 43 (100).





/\..H 22 : 78
19
W:··. . O/ H
18
I




Reagents: a) LiAlH4, THF/reflux/2 h; b) MeLi, ether; after 7 days reflux only
500/0 transformation; c) (AC)20, CHsCOCl/pyridine/400/8 h14; d) (AchO, pyridine/
100°/1 h,
18 and 19 were purified by chromatography on Si02 with cyclohexanejether
95: 5.
(9fJH)-12-Nordriman-8fJ-ot (18). [a]n20 = -39.7°. lH-NMR: 0.845 (s, 3H), 0.873
(s, 3H), 0.905 (d, J = 7, 3H), 1.24 (s, 3H), 3.82 (m, Wl,. = 6, IH). MS: 210 (2, M·+),
192 (7), 177 (37), 137 (35), 124 (73), 109 (85), 95 (55), 81 (77), 69 (69), 55 (72), 41 (100).
(9fJH)-12-Nordriman-8a-ot (19). [aJn20 = _6°. lH-NMR: 0.797 (s, 3H), 0.868
(s, 3H), 0.884 (d, J = 7, 3H), 1.15 (s, 3H), 4.06 (dt, Jl = 12, J2 = 5, IH). MS: 210 (O,
M·+), 208 (5), 192 (13), 177 (100), 163 (11), 149 (17), 137 (42), 124 (43), 109 (56), 95 (43),
81 (51), 69 (42), 41 (48).
(9fJH)-12-Nordriman-8fJ-yt Acetate (21). The product was crystallized from
pentane: m. p. 119-120°, [a]D!O = _6.2°. lH-NMR: 0.78 (s, 3H), 0.81 (s, 3H), 0.884
(d, J = 7, 3H), 1.05 (s, 3H), 4.72 (m, Wl" = 6, IH). MS: 252 (O, M·+), 192 (32), 177 (45),
149 (100), 136 (31), 121 (34), 109 (40), 95 (47), 81 (56), 69 (43), 55 (45), 43 (93).
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(9{JH)-Driman-8{J-ol (38). [aJn20 = -19.8°. lH-NMR: 0.84 (s 3H), 0.874 (s, 3H),
0.90 (d, J = 7, 3H), 1.175 (s, 3H), 1.28 (s, 3H). MS: 224 (4, M·+), 206 (22), 191 (62),
177 (23), 153 (18), 137 (28), 121 (33), 109 (78), 97 (65), 83 (62), 71 (100), 55 (63), 43 (77).
(9{JH)-Driman-8{J-yl Acetate (40). [aJn20 = _9°. lH-NMR: 0.773 (s, 3H), 0.87 (s,
3H), 0.90 (d, J = 7, 3H), 1.09 (s, 3H), 1.46 (s, 3H), 1.98 (s, 3H). MS: 266 (O, M·+), 206 (53),
191 (100), 177 (7), 163 (14), 150 (22), 137 (36), 121 (51), 109 (82), 95 (67), 82 (47), 69 (40),
55 (37), 43 (67).
Preparation of Compound 8.
d e f•. •. ...
X XI XI I
OTs
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Reagents: a) LiAIH4, ether/reflux/5 h; b) (AchO, pyridine/RT.i4 h; c) (AC)20,
CH3COCl/pyridine/400/8 h14; d) N2-stream, 300°; e) NaOH, MeOH/reflux/l h; f) TsCl,
pyridine/-700 ...•.RT.; g) Al(i-Bu)2H, toluene/-750 ...•.RT.lS; h) 03, AcOEt/-100, than
(MehS added ...•.RT./5 h.
13,14,15,16,20-Pentanorlabdan-8-one (8). The product was purified by chroma-
tography on Si02 with hexane/ether 4: 1. [aJn20 = -58.3°. IR: 1705. lH-NMR: 0.70
(s, 3H), 0.81 (t, J = 7, 3H), 0.83 (s, 3H), 0.97 (s, 3H). MS: 222 (49, M·+), 207 (15), 137
(76), 123 (63), 109 (40), 95 (58), 81 (70), 69 (77), 55 (82), 41 (100).
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Reagents: a) LiAIH4, ether/reflux/1 h; b) MeLi, ether/RT./1 h; c) (AchO, CH3COCl/
pyridine/400/5 hl\ d) (AchO, pyridine/RT./20 h.
22 and 23 were purified by chromatography on Si02 with hexanejether 85 : 15.
13,14,15,16,20-Pentanorlabdan-8j3-ol (22). [a]o20 = +20.4°. IR: 3440. lH-NMR: 0.85
(s, 3H), 0.878 (s, 3H), 0.911 (t, J = 7.5, 3H), 0.985 (s, 3H), 4.05 (br. s. W,/, = 8, IH).
MS: 224 (7, M·+), 206 (17), 191 (40), 137 (42), 124 (100), 109 (92), 95 (56), 81 (67), .69
(76), 55 (73), 41 (81).
13,14,15,16,20-Pentanorlabdan-8a-ol (23). [a]o20 = -17.7°. IR (CDCb): 3620, 3450.
lH-NMR: 0.76 (s, 3H), 0.78 (s, 3H), 0.84 (s, 3H), 1.1 (t, J = 7, 3H), 3.55 (m, W'/, = 20,
IH). MS: 224 (1, M·+), 206 (50), 191 (44), 137 (96), 124 (80), 109 (92), 95 (69), 81 (80),
69 (94), 55 (94), 41 (100).
13,14,15,16,20-Pentanorlabdan-8j3-yl Acetate (25). 25 was crystallized from pen-
tane: m. p. 90.5-92°, [a]o20 = +59.8°. IR (CDC13): 1730. lH-NMR: 0.845 (t, J = 7.5,
3H), 0.857 (s, 3H), 0.875 (s, 3H), 0.953 (s, 3H), 2.04 (s, 3H), 5.14 (m, W'/. = 6, IH).
MS: 266 (O, M·+), 206 (30), 191 (42), 177 (19), 136 (57), 124 (82), 109 (47), 95 (41), 81
(51), 69 (52), 55 (51), 43 (100).
13,14,15,16,20-Pentanorlabdan-8a-yl Acetate (26). [a]o20 = -16.5°. IR: 1740.
lH-NMR: 0.82 (s, 3H), 0.83 (s, 3H), 0.88 (s, 3H), 1.02 (t, J = 7, 3H), 2.04 (s, 3H), 4.7
(m, W'h = 20, IH). MS: 266 (O, M·+), 206 «1), 166 (33), 67 (78), 55 (100), 41 (71).
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13,14,15,16-Tetranorlabdan-8p-ol (42). 42 was purified by chromatography on
Si02 with hexane/ether 9: 1. [a]o20 = +8°. IR (CDC1a): 3620, 3480. lH-NMR: 0.83
(s, 3H), 0.85 (s, 3H), 0.84 (s, 3H), 0.98 (t, J = 7, 3H), 1.14 (s, 3H). MS: 238 (30, M·+),
223 (6), 220 (7), 205 (23), 117 (19), 137 (21), 109 (48), 97 (62), 85 (87), 69 (85), 55 (76),
43 (100).
13,14,15,16-Tetranorlabdan-8p-yl Acetate (46). [a]o20 = -39.5°. IR: 1735. lH-NMR:
0.83 (s, 3H), 0.88 (s, 3H), 0.92 (s, 3H), 0.99 (t, J = 7, 3H), 1.52 (s, 3H), 1.99 (s, 3H).
MS: 280 (O, M·+), 220 (27), 205 (20), 137 (25), 124 (35), 109 (56), 96 (100), 81 (53), 69
(44), 55 (52), 43 (78).
Preparation of Compounds 41 and 45.
Scheme 9
OH
a •. b •.
I I 41
Reagents: a) Na OH, (NH2)2'H20/diethylene glycol=e- 190° 9; b) (AchO, CH3COCl/py-
ridine's,
13,14,15,16-Tetranorlabdan-8a-ol (41). 41 was purified by chromatography on
Si02 with cyclohexane/ether 9: 1. [a]o20 ='0°. IR (CDC13): 3620, 3460. lH-NMR: 0.78
(s, 3H), 0.79 (s, 3H), 0.87 (s, 3H), 1.01 (t, J = 7, 3H), .1.14 (s, 3H). MS: 238 (9, M·+),
220 (5), 205 (14), 177 (8), 137 (24), 123 (20), 109 (41), 97 (52), 85 (69), 69 (79), 55 (67)
43 (100).
13,14,15,16-Tetranorlabdan-8a-yl Acetate (45). [a]o20 = +26.5°. IR: 1735. lH-NMR:
0.77 (s, 3H), 0.81 (s, 3H), 0.87 (s, 3H), 1.0 (t, J = 7, 3H), 1.43 (s, 3H), 1.92 (s, 3H).
MS: 280 (O, M·+), 220 (19) 205 (20), 191 (15), 137 (50), 123 (25), 109 (57), 96 (50), 81
(57), 69 (51), 55 (100), 41 (80).
Prepamtion of Compounds 9, 24, 27, 44 and 48.
(9PH)-13,14,15,16-Tetranorlabdan-8(20)-en-12-al (2). [0.]020 = +33.1°. IR: 2730, 1730,
900. lH-NMR: 0.83 (s, 3H), 0.92 (s, 3H), 1.01 (s, 3H), 4.7 (br. s, 2H), 9.63 (m, IH).
MS: 234 (10, M·+), 219 (13), 201 (8), 190 (44), 137 (100), 123 (46), 109 (31), 95 (42), 81
(53),"' 69 (62), 55 (39), 41 (60).
~ (9PH)-13,14,15,16,20-Pentanorlabdan-8-one (9). [a]o20 = -8.9°. IR: 1710. lH-NMR:
0.80 (t, J = 7, 3H), 0.87 (s, 3H), 0.93 (s, 3R), 0.96 (s, 3H). MS: 222 (62, M·+), 207 (18),
189 (18), 179 (22), 166 (23), 151 (24), 137 (100), 123 (77), 109 (50), 95 (67), 81 (73), 69
(86), 55 (82), 41 (92).
(9PH)-13,14,15,16,20-Pentanorlabdan-8p-ol (24). M. p. 104-105°, [a]o20 = -44.4°.
IR (CDC13): 3630, 3460. lH-NMR: 0.84 (s, 3H), 0.859 (s, 3H), 0.917 (t J = 7, 3H), 1.24
(s, 3H), 3.98 (br. s, IH). MS: 224 (2,M·+), 206, (10), 191 (31), 137 (43), 124 (100), 109
(83), 95 (52), 81 (61), 69 (67), 55 (63), 41 (69).
(9PH)-13,14,15,16,20-Pentanorlabdan-Sp-yl Acetate (27). [a.]n20 = -23.6°. IR
(CDC13): 1725. lH-NMR: 0.842 (s, 3H), 0.865 (s, 3H), 0.974 (t, J = 7, 3H), 1.133 (s, 3H),
r
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Reagents: a) HCOOH (98°/e), conc. H2S04/9oo/8 h9; b) LiAlH4, ether/reflux/1 h; c)
(AchO, pyridine/RT./8 h; d) POC13, pyridine/-20o -+ RT.; e) NaOH, MeOH/reflux/1
h; f) PDC, CH2C1218;g) NaOH, (NH2h' H20/ diethylene glycol.-e- 109° 17; h) 03/AcOEt,
then PPh3/-700 -+ RT.; i) MeLi/ether; after 60 h at RT. only 600/0 transformation;
j) (AchO, CH3COCl/pyridine/40o/8 h14.
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2.03 (s, 3H), 4.97 (m, WIll = 5, IH). MS: 266 (O, M·+), 206 (50), 191 (57), 177 (55), 149
(55), 136 (56), 121 (40), 109 (55), 95 (51), 81 (57), 69 (64), 55 (56), 43 (100).
(9PH)-13,14,15,16-Tetranorlabdan-8p-ol (44). M. p. 70°, [a]n20 = -25°. IR (CDC1a):
3620, 3450. lH-NMR: 0.827 (s, 3H), 0.856 (s, 3H), 0.933 (t, J = 7.5, 3H), 1.245 (s, 3H),
1.265 (s, 3H). MS: 238 (10, M·+), 220 (12), 205 (30), 177 (23), 137 (30), 123 (35), 109
(85), 97 (61), 81 (93), 69 (100), 55 (89), 43 (91).
(9PH)-13,14,15,16-Tetranorlabdan-8p-yl Acetate (48). [a]n20 = -4.6°. IR (CDC13):
l720. lH-NMR: 0.815 (s, 3H), 0.885 (s, 3H), 0.972 (t, J = 7, 3H), 1.09 (s, 3H), 1.53
(s, 3H), 1.975 (s, 3H). MS: 280 (O,M·+), 220 (10), 205 (13), 191 (19), 137 (33), 109 (78),
96 (57), 81 (71), 69 (53), 55 (67), 41 (100).








Reagents: a) Al(i-BuhH, toluenej-700 13, b) NaOH, (NH2h'H20jdiethylene glycof.-e-
190° 17; c) (AchO, CH3COCl/pyridine/400/5 h14.
(9PH)-13,14,15,16-Tetranorlabdan-8a-ol (43). The product was purified by chro-
matography on Si02 with cyclohexanejether 4: 1. [a]D20 = -26°. IR: 3450. lH-NMR:
0.78 (s, 3H), 0.86 (s, 3H), 0.94 (t, J = 7, 3H), 1.07 (s, 3H), 1.44 (s, 3H). MS: 238 (14,
M·+), 220 (16), 205 (23), 177 (21), 137 (66), 123 (35), 111 (59), 97 (81), 85 (100), 69 (99),
55 (80), 43 (91).
(9pH)13,14,15,16-Tetranorlabdan-8a-yl Acetate (47). [U]n20 = +8.73°. IR: 1740.
lH-NMR: 0.80 (s, 3H), 0.88 (s, 3H), 1.0 (t, J = 7, 3H), 1.1 (s, 3H), 1.72 (s, 3H), 1.99
(s, 3H) MS: 280 (O,M·+), 220 (2), 205 (1), 182 (16), 137 (16), 126 (43), 109 (27), 99 (27),
82 (37), 69 (35), 57 (76), 43 (100).
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Reagents: a) 03, AcOEtj-700, than PPh3 --+ RT.; b) ethylene glycol, toluenejp-TsOHj
refluxj5 h; c) NaOH, MeOHjrefluxjl h; d) PDC, CH2C1216;e) PPh3MeJ-BuLi/etherj
refluxj60 h18; f) diluted HCI, MeOHjRT.; g) H2, PdjC (5%), AcOEt.
14,15,16,20-Tetranorlabdan-8-one (10). [aJn!O == -44°. IR: 1710. lH-NMR: 0.707
(s, 3H), 0.845 (s, 3H), 0.87 (t, J == 7, 3 H), 0.978 (s, 3H). MS: 236 (27, M·+) , 207 (25),
179 (90), 137 (53), 123 (42), 109 (33), 95 (50), 81 (61), 69 (70), 55 (100), 41 (97).
Preparation of Compounds 28, 29, 31, 32, 50 and 53.
The two alcohols 28 and 29 were separated by chromatography on Si02 with
cyclohexanejether 96 : 4.
14,15,16,20-Tetranorlabdan-8fJ-ol (28). [a1020 == +34.4°. IR (CDCh): 3640, 3480.
lH-NMR: 0.84 (s, 3H), 0.865 (s, 3H), 0.905 (t, J == 7, 3H), 0.975 (s, 3H), 3.97 (m, W1/. == 8,
1H). MS: 238 (4, M·+), 220 (7), 205 (30), 137 (35), 124 (93), 109 (91), 95 (49), 81 (65),
69 (90), 55 (85), 41 (100).
14,15,16,20-Tetranorlabdan-8a-ol (29). [a1020 == -10.2°. IR (CDCh): 3620, 3450.
lH-NMR: 0.79 (s, 3H), 0.77 (s, 3H), 0.86 (s, 3H), 0.89 (t, J == 7, 3H), 3.44 (m, W1/, == 20,
1H). MS: 238 (O, M·+), 220 (4), 205 (5), 137 (26), 124 (21), Hl9 (100), 95 (13), 81 (25), f












Reagents: a) LiAIH4, ether/reflux/3 h; b) MeMgI, ether/reflux/3 h ; c) (AC)20, pyridine/
RT./18 h; d) (AchO, CHaCOCl/pyridine/400/5 h 14.
14,15,16,20-Tetranorlabdan-8p-yl Acetate (31). [a]o20 = +64.6°. IR: 1730.
1H-NMR: 0.855 (s, 3H), 0.875 (s, 3H), 0.86 (t, J = 7, 3H), 0.955 (s, 3H), 2.04 (s, 3H),
5.07 (m, Wl/, = 8, IH). MS: 280 (O, M·+), 220 (44), 205 (56), 177 (34), 136 (80), 124
(100), 109 (55), 96 (45), 81 (54), 69 (58), 55 (96), 43 (94).
14,15,16,20-Tetranorlabdan-8a-yl Acetate (32). [a]o20 = -18°. IR: 1740. 1H-NMR:
0.79 (s, 3H), 0.81 (s, 3H), 0.84 (t, J = 7, 3H), 0.855 (s, 3H). 2.0 (s, 3H), 4.72 (m, IH).
MS: 280 (1, M·+), 220 (40), 205 (48), 177 (31), 137 (67), 124 (70), 109 (50), 95 (43), 81
(54), 69 (55), 55 (62), 43 (100).
14,15,16-Trinorlabdan-8p-ol (50). [a]o20 = + 10.2°. IR (CDCls): 3630, 3470. 1H-NMR:
0.83 (s, 3H), 0.88 (s, 3H), 0.91 (t, J = 7, 3H), 0.96 (s, 3H), 1.13 (s, 3H), MS: 252 (32,
M·+) , 237 (6), 234 (8), 219 (32), 205 (21), 195 (20), 177 (32), 137 (33), 125 (43), 109 (46),
99 (92), 81 (53), 69 (100), 55 (70), 43 (86).
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14,15,16-Trinorlabdan-8(J-yl Acetate (53). [a]D!O= +37°. IR (CDCls): 1725. lH-NMR:
0.82 (s, 3H), 0.85 (t, J = 7, 3H), 0.87 (s, 3H), 0.91 (s, 3H), 1.48 (s, 3H), 1.98 (s, 3H).
MS: 294 (O, M·+), 234 (21), 219 (14), 191 (7), 177 (8), 137 (33), 124 (30), 110 (100), 95
(35), 81 (45), 69 (35), 55 (37), 43 (50).







Reagents: a) PPh3CH30/BuLi, ether/RT./2 h19; b) Pt02, H2, AcOEt; c) (AC)20,
CH3COCl/. pyridine/40o/8 h14.
The crude mixture of 49 was purified by chromatography on Si02 with cyclo-
hexane/ether 93 : 7.
14,15,16-Trinorlabdan-8a-ol (49). [a]o20. = -4.7°. IR (CDC1a): 3620, 3470. lH'-NMR:
0.79 (s, 3H), 0.81 (s, 3H), 0.88 (s, 3H), 0.92 (t, J = 7, 3H), 1.16 (s, 3H). MS: 252
(21, M.+), 234 (8), 219 (16), 205 (7), 195 (11), 177 (22), 137 (29), 125 (45), 111 (46), 99
(80), 83 (49), 69 (100), 55 (70), 43 (82).
14,15,16-Trinorlabdan-8a-yl Acetate (52). [a]o20 = -28.3°. IR (CDCl3): 1720.
lH-NMR: 0.78 (s, 3H), 0.82 (s, 3H), 0.86 (s, 3H), 0.89 (t, J = 7, 3H), 1.45 (s, 3H),
1.92 (s, 3H).
Preparation of Compound 11.
(9(JH)-14,15,16-Trinorlabd-8(20)-en-12-one (4). [a]o20 = _5.2°. IR: 1710, 885. -a-
-NMR: 0.815 (s, 3H), 0.89 (s, 3H), 0.97 (s, 3H), 4.6 and 4.67 (two br. s, 2H). MS:
248 (2, M·+), 233 (5), 215 (6), 190 (62), 137 (47), 109 (37), 95 (48), 81 (62), 69 (53), 55
(35), 43 (100).
Ketone 11 was purified by prep. gas chromatography,
(9(JH)-14,15,16,20-Tetranorlabdan-8-one (11). M. p. 67.5° [aJn20 = -14.3°. lH-NMR:




































































































































































































































































































































































































































































































































































































































































































Reagents: a) MeMgI, ether/reflux/ž h; b) PDC, CH2C1216;c) NaOH, (NH2h'H20!
diethylene glycol=-s- 190° 17; d) 03, AcOEt!-700, than PPh3 -+ RT.
(3), 207 (11), 194 (37), 179 (100), 137 (39), 123 (28), 109 (30), 95 (45), 81 (53), 69 (51),
55 (82), 41 (84).




















Reagents: a) NaBH4, EtOH!RT.!4 h; b) (AchO, pyridine!RT'/12 h ; c) MeMgJ,




























Reagents: a) HCOOH (980/0), conc. H2S04/200/4 h9: b) like a) but 95°/5 h9; c)
LiAIH4, ether/reflux/1 h ; d) p'BrPhCOCl, pyridine/RT./20 h, then (AchO, CH3COCl/
pyridine/400/18 h14.
(9jJH)-14,15,16,20-Tetranorlabdan-8jJ-ol (30). M. p. 68-69°, [a]o20 == -42.4°. IR
(CDC13): 3630, 3460. lH-NMR: 0.83 (s, 3H), 0.855 (s, 3H), 0.885 (t, J == 7, 3H), 1.235
(s, 3H), 3.92 (m, w'/. = 6, IH). MS: 238 (1, M·+), 220 (2), 205 (8), 137 (17), 124 (53),
109 (76), 95 (38), 81 (58), 69 (61), 55 (75), 41 (100).
(9jJH)-14,15,16,20-Tetranorlabdan-8jJ-yl Acetate (33). [a]o20 = -23.2°. IR: 1740.
lH-NMR: 0.84 (s, 3H), 0.87 (s, 3H), 0.90 (t, J = 7, 3H), 1.12 (s, 3H), 2.02 (s, 3H), 4.91
(m, w'/. = 4, IH). MS: 280 (O, M·+) , 220 (19), 205 (27), 177 (45), 149 (43), 124 (39), 109
(83), 95 (48), 81 (57), 69 (49), 55 (58), 43 (100).
(9jJH)-14,15,16-Trinorlabdan-8jJ-ol (51). [a1020 == _25°. IR (CDC13): 3620 ,3450.
lH-NMR: 0.825 (s, 3H), 0.86 (s, 3H), 0.88 (t, J == 7, 3H), 1.23 (s, 3H), 1.26 (s, 3H).
MS: 252 (3, M·+), 234 (5), 219 (13), 191 (7), 177 (13), 137 (28), 123 (25), 109 (54), 95
(49), 81 (63), 69 (89), 55 (77), 43 (100).
j
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Table 2. 13C_NMR chemical shifts of the compounas VIII, XVI,
XXXIII, XXXIV and XXXV
compound VIlI XVI XXXIII XXXIV XXXV
carbon
1 39.4 37.8 39.3 39.4 39.4
2 18.5 18.6 18.3 18.4 18.2
3 41.9 42.3 42.2 41.9 41.9
4 33.3 ' 32.9 33.3 33.2 33.4
5 56.1 46.5 55.9 55.7 55.9
6 20.5 20.8 18.1 20.3 18.2
7 44.1 36.8 41.9 38.9 35.9
8 72.7 72.9 72.9 87.0 84.5
9 59.4 58.0 54.6 55.2 57.1
10 39.0 38.6 38.5 39.1 38.9
11 27.9 '29.5 28.7 25.1 24.6
12 63.8 64.2 64.9 66.7 66.8
17 15.3 24.6 15.1 15.6 15.O
18 33.5 33.1 33.4 33.3 33.4
19 21.5 21.3 21.6 21.5 21. 7
20 24.5 31.9 30.7 19.9 25.5
(9(JH)-14,15,16-Trinorlabdan-8(J-yl Acetate (54). [aJn20 = -11.5°, IR: 1740. 1H-
-NMR: 0.82 (s, 3H), 0.86 (s, 3H), 0.89 (t, J = 7, 3H), 1.075 (s, 3H), 1.52 (s, 3H), 1.97
(s, 3H), MS: 294 (O, M·+) , 234 (13), 219 (13), 191 (27), 177 (6), 163 (6), 137 (37), 123 (27),
109 (55), 95 (56), 81 (63), 69 (54), 55 (70), 43 (100).
Preparation of Compounds XVI, ~XXIV and XXXV.
The diols VIlI, XXXIII and XVI were prepared from the corresponding
lactones by reduction. Product VIlI and XXXIII were further transformed into
the 8-acetoxy-12-(4)-bromobenzoyl derivatives XXXIV and XXXV for the deter-
mination of stereochemistry, absolute structure and conformation by X-ray di-
ffraction analysis. Product XVI was directly taken for this measurement-".
(9(JH)-13,14,15,16-Tetranorlabdane-8a,12-diol. (XVI). M. p. 110-111°, [aD]2° == :-
-13.6°. 1H-NMR: 0.79 (s, 3H), 0.85 (s, 3H), 1.10 (s, 3H), 1.49 (s, 3H), 3.39 and 3.75
(2 m, 2H).
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8a-Acetoxy-12-(4-bromobenzoyloxY)-13,14,15,16-tetranorlab dane (XXXIV). M. p.
88-90.5°, [a]D20 = +2.1°. lH-NMR: 0.79 (s, 3H), 0.856 (s, 3H), 0.872 (s, 3H), 1.52 (s, 3H),
1.95 (s, 3H), 2.84 (m, IH), 4.30 (ddd, J = tt.!ll N) 4.41 (ddd, J = 6,5, IH), 7.85 (splitted
d, J = 7,5, 2H), 7.92 (splited d, J = 7.5, 2H).
8jJ-Acetoxy-12-(4-bromobenzoyloxy)-13,14,15,16-tetranorlabdane (XXXV). M. p.
109-1'11°, [a]o20 = + 31.6°. lH-NMR: 0.828 (s, 3H), 0.87 (s, 3H), 0.945 (s, 3H), 1.55
(s, 3H), 1.98 (s, 3H), 4.3 (m, 2H), 7.6 (d/t, h = 8, J2 = 3, 2H), 7.9 (d/t, JI = 8,
J2 = 3, 2H).
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Odnosi strukture i aktivnosti pri mirisnoj percepciji drimanskih derivata
Gilnther Ohloff i Wolfgang Giersch
Drvenast mIrIS trans-dekalonskih derivata tipa 5, sličan sivom amberu, poja-
čava se sa uvođenjem ekvatorijalnih alkil-supstituenata u položaj 9, a drastično
slabi kod odgovarajućih 9-epi-derivata. Potpuna stereokontrola mirisne percepcije
zapažena je kod diastereoizomera i'-biciklohomoiarnezala 1 i 2. Slična težnja u
mirisnoj percepciji pnimećena je kod supstituisanih alkohola tipa 12, ali nesumnjivo,
sa neizvesnijom pravilnošću. Mirisni ton sivog ambera sličan sandalovini nađen
kod »Polywood"?« (14) iščezava u odgovarajućim alkil-supstituisanim acetatima.
Molekulska osnova mirisa »steroidnog tipa« nekih estara tipa 39 do sada nije bila
poznata.
J
